CION Ameerpet
Contrast MRI does most of the work in a brain tumour. A PET scan is a problem-solver added in specific situations — and a DOTATATE-PET is especially useful for meningiomas. CION reads every PET alongside your MRI, so you only scan when it helps.
If your brain tumour work-up has reached the word "PET," it helps to know where this scan fits. A PET (positron-emission tomography) scan does not show fine anatomy — it shows activity. A tiny amount of a tracer is injected, and the scanner maps where that tracer collects, hinting at how active or what type a tumour is. It is almost always combined with CT as a "PET-CT".
For brain tumours, the contrast MRI is the workhorse — it answers most questions about size, location and likely nature. Both NCCN and EANO guidance treat PET as a problem-solver that is added in specific situations, not a routine first scan. So if your doctor has not ordered a PET, that is often a good sign: your MRI has answered the question.
The normal brain runs almost entirely on sugar (glucose). Because the common PET tracer FDG is a sugar, healthy brain tissue lights up brightly — which can hide a small or low-grade tumour against that glowing background. This is exactly why specialised amino-acid and DOTATATE tracers, which the normal brain does not take up, often give a clearer picture for brain tumours (EANO/RANO PET guidance).
A PET is worth doing when it answers a question your MRI cannot — and would change what happens next. These are the situations where it most often helps.
After radiation, an MRI spot can look like growing tumour but actually be radiation necrosis — treated, dead tissue. The two look alike on MRI. Because true tumour is metabolically active, PET can help tell them apart, which decides whether you need more treatment or simple monitoring.
Meningiomas carry somatostatin receptors that the DOTATATE tracer binds to — so they glow while normal brain stays dark. This is especially useful for skull-base meningiomas before radiation planning, or to find leftover or recurrent tumour after surgery.
When a tumour is not uniform, PET can highlight the most active region — so a biopsy is taken from the part most likely to give the true diagnosis and grade, rather than a quieter, less representative area.
If a scan finds a brain lesion that looks like a metastasis (spread from elsewhere), a whole-body FDG PET-CT can help find the original cancer — in the lung, breast, kidney or skin — so the right primary team is involved early.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Our tumour board reviews your MRI, decides whether a PET helps, and coordinates the scan at an accredited partner — then plans your care. Decisions for healing, not billing.
"PET scan" is not one test. The tracer decides what the scan can see — and the right tracer depends on the question being asked. Your oncologist chooses it; you do not have to.
| Tracer | What it shows | Best used for |
|---|---|---|
| FDG (sugar) | How much glucose cells burn | Telling recurrence from radiation change; finding a hidden primary in suspected brain metastases (whole-body) |
| DOTATATE (Ga-68) | Somatostatin receptors on tumour cells | Mapping meningiomas before radiation; spotting residual or recurrent meningioma |
| Amino-acid (FET / DOPA) | Amino-acid uptake by tumour cells | Seeing gliomas against the dark normal-brain background; biopsy targeting and recurrence assessment |
Availability of amino-acid tracers varies between imaging centres. CION coordinates the scan at an accredited partner that can perform the tracer your case needs, and reads it with your MRI. PET is always interpreted alongside MRI — never on its own. (EANO/RANO PET working-group recommendations.)
A PET-CT is non-invasive and usually an outpatient appointment. Here is what to expect:
A PET scan is never read in isolation for a brain tumour. International guidance (EANO and the RANO PET working group) recommends that brain PET is always interpreted side by side with a recent contrast MRI. That is why a joined-up team matters — the same tumour board that knows your MRI should read your PET.
Imaging decisions shape everything that follows, so it is reasonable to pause and confirm the plan. A second opinion is especially worthwhile if:
At CION, we deliver imaging review, diagnosis, molecular testing, radiation therapy and systemic treatment directly, and we coordinate any PET-CT and neurosurgery with accredited partners — so you get one plan, not scattered reports. We walk this journey with you, with transparent costs and a 45-minute consultation.
Understanding brain tumour imaging is easier when the pieces connect. Start with the basics and move to treatment:
Share your MRI or PET report with CION's neuro-oncology team for a free written second opinion — clear answers in plain language, no commitment to start treatment.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.For most brain tumours, contrast MRI is the main imaging test — and a PET scan is not routinely needed. NCCN and EANO guidance treat PET as a problem-solver, not a first test. Your doctor may add a PET scan in specific situations: telling tumour recurrence apart from radiation change after treatment, picking the most active spot for a biopsy, or — with a DOTATATE PET — mapping a meningioma before radiation. If your question is fully answered by MRI, you will not need a PET. Our tumour board reviews each scan and recommends a PET only when it will genuinely change your plan.
They use different tracers and answer different questions. FDG-PET uses a sugar tracer and shows how active cells are — but the normal brain already burns a lot of sugar, so small or low-grade tumours can be hard to see against that bright background. DOTATATE-PET (and amino-acid tracers such as FET or DOPA) bind to targets that the normal brain does not light up — giving a much clearer tumour-to-background picture. DOTATATE-PET is especially useful for meningiomas, which carry the somatostatin receptors the DOTATATE tracer locks onto. Your oncologist chooses the tracer based on the question being asked.
Meningiomas strongly express somatostatin receptor type 2, and the DOTATATE tracer is built to bind exactly that receptor. So a meningioma lights up vividly on DOTATATE-PET, while the surrounding normal brain stays dark. This is most valuable when a meningioma sits at the skull base or near bone, where it can be hard to separate tumour from normal tissue on MRI alone. DOTATATE-PET helps the radiation oncologist draw a precise target before radiation planning, confirm leftover tumour after surgery, and detect recurrence. At CION the scan is read alongside your MRI by our tumour board.
This is one of the most useful jobs a brain PET does. After radiation, MRI can show an area that looks like growing tumour but is actually radiation necrosis — dead, treated tissue that swells and takes up contrast. The two can look almost identical on MRI. Because true tumour is metabolically active and radiation change is not, an amino-acid or FDG-PET can help tell them apart. This matters: recurrence may need more treatment, while radiation change is managed differently. PET is one input — your oncologist weighs it with serial MRI and your symptoms before deciding.
A PET-CT is safe and non-invasive. A small amount of a short-lived radioactive tracer is injected into a vein, you rest quietly while it circulates (about 45–60 minutes for FDG; timing varies for DOTATATE), then you lie still in the scanner for 15–30 minutes. The radiation dose is low and the tracer leaves your body within hours — drinking water helps clear it. You can usually drive home and return to normal activity the same day. Tell the team if you are diabetic (sugar levels affect FDG), pregnant, or breastfeeding. CION coordinates PET-CT at accredited imaging partners and reads it with your MRI.
PET-CT pricing varies by the tracer used, the imaging centre, and whether it is a brain-only or whole-body study — DOTATATE and amino-acid tracers usually cost more than standard FDG because they are specialised. Rather than quote a figure that may not fit your scan, CION gives you a clear, itemised estimate after reviewing your MRI and the clinical question. We coordinate the scan at accredited partner centres and explain costs upfront. Request a cost estimate or call 18002028726 — decisions for healing, not billing.
CION delivers imaging review, diagnosis, molecular testing, radiation therapy and systemic treatment directly. PET-CT itself is performed at accredited imaging partners that we coordinate for you — so the right tracer is chosen, the scan is done to protocol, and the images come straight back to our tumour board to be read alongside your MRI. You get one joined-up plan instead of scattered reports. Book a 45-minute consultation and we will tell you whether a PET adds value in your case before any scan is ordered.
Disclaimer: This content is intended for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified oncologist for guidance specific to your medical condition. The information on this page is periodically reviewed and updated by CION's medical team in accordance with current clinical guidelines.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.